A fetal wave of human type 3 effector γδ cells with restricted TCR diversity persists into adulthood.


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
23 04 2021
Historique:
received: 28 09 2020
revised: 17 12 2020
accepted: 24 03 2021
entrez: 24 4 2021
pubmed: 25 4 2021
medline: 1 3 2022
Statut: ppublish

Résumé

Accumulating evidence suggests that the mouse embryonic thymus produces distinct waves of innate effector γδ T cells. However, it is unclear whether this process occurs similarly in humans and whether it comprises a dedicated subset of innate-like type 3 effector γδ T cells. Here, we present a protocol for high-throughput sequencing of

Identifiants

pubmed: 33893173
pii: 6/58/eabf0125
doi: 10.1126/sciimmunol.abf0125
pii:
doi:

Substances chimiques

Receptors, Antigen, T-Cell, gamma-delta 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Likai Tan (L)

Institute of Immunology, Hannover Medical School (MHH), Hannover, Germany.
Institute of Systems Immunology, Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Alina Suzann Fichtner (AS)

Institute of Immunology, Hannover Medical School (MHH), Hannover, Germany.

Elena Bruni (E)

Institute of Immunology, Hannover Medical School (MHH), Hannover, Germany.

Ivan Odak (I)

Institute of Immunology, Hannover Medical School (MHH), Hannover, Germany.

Inga Sandrock (I)

Institute of Immunology, Hannover Medical School (MHH), Hannover, Germany.

Anja Bubke (A)

Institute of Immunology, Hannover Medical School (MHH), Hannover, Germany.

Alina Borchers (A)

Translational Immunology, III. Department of Medicine, Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Christian Schultze-Florey (C)

Institute of Immunology, Hannover Medical School (MHH), Hannover, Germany.
Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.

Christian Koenecke (C)

Institute of Immunology, Hannover Medical School (MHH), Hannover, Germany.
Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.

Reinhold Förster (R)

Institute of Immunology, Hannover Medical School (MHH), Hannover, Germany.
Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.

Michael Jarek (M)

Genome Analytics, Helmholtz Centre for Infection Research, Braunschweig, Germany.

Constantin von Kaisenberg (C)

Department of Obstetrics, Gynecology, and Reproductive Medicine, Hannover Medical School, Hannover, Germany.

Ansgar Schulz (A)

Department of Pediatrics, University Medical Center Ulm, Ulm, Germany.

Xiaojing Chu (X)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, Netherlands.
Department of Computational Biology for Individualised Medicine TWINCORE, Helmholtz Centre for Infection Research and Hannover Medical School, Hannover, Germany.

Bowen Zhang (B)

Department of Computational Biology for Individualised Medicine TWINCORE, Helmholtz Centre for Infection Research and Hannover Medical School, Hannover, Germany.

Yang Li (Y)

Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.
Department of Computational Biology for Individualised Medicine TWINCORE, Helmholtz Centre for Infection Research and Hannover Medical School, Hannover, Germany.

Ulf Panzer (U)

Translational Immunology, III. Department of Medicine, Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Christian F Krebs (CF)

Translational Immunology, III. Department of Medicine, Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Sarina Ravens (S)

Institute of Immunology, Hannover Medical School (MHH), Hannover, Germany.
Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.

Immo Prinz (I)

Institute of Immunology, Hannover Medical School (MHH), Hannover, Germany. i.prinz@uke.de.
Institute of Systems Immunology, Hamburg Center for Translational Immunology (HCTI), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Cluster of Excellence RESIST (EXC 2155), Hannover Medical School, Hannover, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH